author_facet D'Cruz, Osmond
Qazi, Sanjive
Hwang, Larn
Ng, Kevin
Trieu, Vuong
D'Cruz, Osmond
Qazi, Sanjive
Hwang, Larn
Ng, Kevin
Trieu, Vuong
author D'Cruz, Osmond
Qazi, Sanjive
Hwang, Larn
Ng, Kevin
Trieu, Vuong
spellingShingle D'Cruz, Osmond
Qazi, Sanjive
Hwang, Larn
Ng, Kevin
Trieu, Vuong
OncoTargets and Therapy
Impact of targeting transforming growth factor β-2 with antisense OT-101 on the cytokine and chemokine profile in patients with advanced pancreatic cancer
Pharmacology (medical)
Oncology
author_sort d'cruz, osmond
spelling D'Cruz, Osmond Qazi, Sanjive Hwang, Larn Ng, Kevin Trieu, Vuong 1178-6930 Informa UK Limited Pharmacology (medical) Oncology http://dx.doi.org/10.2147/ott.s161905 Impact of targeting transforming growth factor β-2 with antisense OT-101 on the cytokine and chemokine profile in patients with advanced pancreatic cancer OncoTargets and Therapy
doi_str_mv 10.2147/ott.s161905
facet_avail Online
Free
finc_class_facet Chemie und Pharmazie
Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMjE0Ny9vdHQuczE2MTkwNQ
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMjE0Ny9vdHQuczE2MTkwNQ
institution DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
imprint Informa UK Limited, 2018
imprint_str_mv Informa UK Limited, 2018
issn 1178-6930
issn_str_mv 1178-6930
language English
mega_collection Informa UK Limited (CrossRef)
match_str dcruz2018impactoftargetingtransforminggrowthfactorb2withantisenseot101onthecytokineandchemokineprofileinpatientswithadvancedpancreaticcancer
publishDateSort 2018
publisher Informa UK Limited
recordtype ai
record_format ai
series OncoTargets and Therapy
source_id 49
title Impact of targeting transforming growth factor β-2 with antisense OT-101 on the cytokine and chemokine profile in patients with advanced pancreatic cancer
title_unstemmed Impact of targeting transforming growth factor β-2 with antisense OT-101 on the cytokine and chemokine profile in patients with advanced pancreatic cancer
title_full Impact of targeting transforming growth factor β-2 with antisense OT-101 on the cytokine and chemokine profile in patients with advanced pancreatic cancer
title_fullStr Impact of targeting transforming growth factor β-2 with antisense OT-101 on the cytokine and chemokine profile in patients with advanced pancreatic cancer
title_full_unstemmed Impact of targeting transforming growth factor β-2 with antisense OT-101 on the cytokine and chemokine profile in patients with advanced pancreatic cancer
title_short Impact of targeting transforming growth factor β-2 with antisense OT-101 on the cytokine and chemokine profile in patients with advanced pancreatic cancer
title_sort impact of targeting transforming growth factor β-2 with antisense ot-101 on the cytokine and chemokine profile in patients with advanced pancreatic cancer
topic Pharmacology (medical)
Oncology
url http://dx.doi.org/10.2147/ott.s161905
publishDate 2018
physical 2779-2796
description
container_start_page 2779
container_title OncoTargets and Therapy
container_volume Volume 11
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792335884064915465
geogr_code not assigned
last_indexed 2024-03-01T14:51:15.726Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Impact+of+targeting+transforming+growth+factor+%CE%B2-2+with+antisense+OT-101+on+the+cytokine+and+chemokine+profile+in+patients+with+advanced+pancreatic+cancer&rft.date=2018-05-01&genre=article&issn=1178-6930&volume=Volume+11&spage=2779&epage=2796&pages=2779-2796&jtitle=OncoTargets+and+Therapy&atitle=Impact+of+targeting+transforming+growth+factor+%26beta%3B-2+with+antisense+OT-101+on+the+cytokine+and+chemokine+profile+in+patients+with+advanced+pancreatic+cancer&aulast=Trieu&aufirst=Vuong&rft_id=info%3Adoi%2F10.2147%2Fott.s161905&rft.language%5B0%5D=eng
SOLR
_version_ 1792335884064915465
author D'Cruz, Osmond, Qazi, Sanjive, Hwang, Larn, Ng, Kevin, Trieu, Vuong
author_facet D'Cruz, Osmond, Qazi, Sanjive, Hwang, Larn, Ng, Kevin, Trieu, Vuong, D'Cruz, Osmond, Qazi, Sanjive, Hwang, Larn, Ng, Kevin, Trieu, Vuong
author_sort d'cruz, osmond
container_start_page 2779
container_title OncoTargets and Therapy
container_volume Volume 11
description
doi_str_mv 10.2147/ott.s161905
facet_avail Online, Free
finc_class_facet Chemie und Pharmazie, Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMjE0Ny9vdHQuczE2MTkwNQ
imprint Informa UK Limited, 2018
imprint_str_mv Informa UK Limited, 2018
institution DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14
issn 1178-6930
issn_str_mv 1178-6930
language English
last_indexed 2024-03-01T14:51:15.726Z
match_str dcruz2018impactoftargetingtransforminggrowthfactorb2withantisenseot101onthecytokineandchemokineprofileinpatientswithadvancedpancreaticcancer
mega_collection Informa UK Limited (CrossRef)
physical 2779-2796
publishDate 2018
publishDateSort 2018
publisher Informa UK Limited
record_format ai
recordtype ai
series OncoTargets and Therapy
source_id 49
spelling D'Cruz, Osmond Qazi, Sanjive Hwang, Larn Ng, Kevin Trieu, Vuong 1178-6930 Informa UK Limited Pharmacology (medical) Oncology http://dx.doi.org/10.2147/ott.s161905 Impact of targeting transforming growth factor β-2 with antisense OT-101 on the cytokine and chemokine profile in patients with advanced pancreatic cancer OncoTargets and Therapy
spellingShingle D'Cruz, Osmond, Qazi, Sanjive, Hwang, Larn, Ng, Kevin, Trieu, Vuong, OncoTargets and Therapy, Impact of targeting transforming growth factor β-2 with antisense OT-101 on the cytokine and chemokine profile in patients with advanced pancreatic cancer, Pharmacology (medical), Oncology
title Impact of targeting transforming growth factor β-2 with antisense OT-101 on the cytokine and chemokine profile in patients with advanced pancreatic cancer
title_full Impact of targeting transforming growth factor β-2 with antisense OT-101 on the cytokine and chemokine profile in patients with advanced pancreatic cancer
title_fullStr Impact of targeting transforming growth factor β-2 with antisense OT-101 on the cytokine and chemokine profile in patients with advanced pancreatic cancer
title_full_unstemmed Impact of targeting transforming growth factor β-2 with antisense OT-101 on the cytokine and chemokine profile in patients with advanced pancreatic cancer
title_short Impact of targeting transforming growth factor β-2 with antisense OT-101 on the cytokine and chemokine profile in patients with advanced pancreatic cancer
title_sort impact of targeting transforming growth factor β-2 with antisense ot-101 on the cytokine and chemokine profile in patients with advanced pancreatic cancer
title_unstemmed Impact of targeting transforming growth factor β-2 with antisense OT-101 on the cytokine and chemokine profile in patients with advanced pancreatic cancer
topic Pharmacology (medical), Oncology
url http://dx.doi.org/10.2147/ott.s161905